Literature DB >> 26305294

Treating Brain Tumor with Microbeam Radiation Generated by a Compact Carbon-Nanotube-Based Irradiator: Initial Radiation Efficacy Study.

Hong Yuan1,2, Lei Zhang3, Jonathan E Frank2, Christina R Inscoe3,4, Laurel M Burk4, Mike Hadsell4, Yueh Z Lee1,2,4,5,6, Jianping Lu3,4, Sha Chang4,5,7,6, Otto Zhou3,4,6.   

Abstract

Microbeam radiation treatment (MRT) using synchrotron radiation has shown great promise in the treatment of brain tumors, with a demonstrated ability to eradicate the tumor while sparing normal tissue in small animal models. With the goal of expediting the advancement of MRT research beyond the limited number of synchrotron facilities in the world, we recently developed a compact laboratory-scale microbeam irradiator using carbon nanotube (CNT) field emission-based X-ray source array technology. The focus of this study is to evaluate the effects of the microbeam radiation generated by this compact irradiator in terms of tumor control and normal tissue damage in a mouse brain tumor model. Mice with U87MG human glioblastoma were treated with sham irradiation, low-dose MRT, high-dose MRT or 10 Gy broad-beam radiation treatment (BRT). The microbeams were 280 μm wide and spaced at 900 μm center-to-center with peak dose at either 48 Gy (low-dose MRT) or 72 Gy (high-dose MRT). Survival studies showed that the mice treated with both MRT protocols had a significantly extended life span compared to the untreated control group (31.4 and 48.5% of life extension for low- and high-dose MRT, respectively) and had similar survival to the BRT group. Immunostaining on MRT mice demonstrated much higher DNA damage and apoptosis level in tumor tissue compared to the normal brain tissue. Apoptosis in normal tissue was significantly lower in the low-dose MRT group compared to that in the BRT group at 48 h postirradiation. Interestingly, there was a significantly higher level of cell proliferation in the MRT-treated normal tissue compared to that in the BRT-treated mice, indicating rapid normal tissue repairing process after MRT. Microbeam radiation exposure on normal brain tissue causes little apoptosis and no macrophage infiltration at 30 days after exposure. This study is the first biological assessment on MRT effects using the compact CNT-based irradiator. It provides an alternative technology that can enable widespread MRT research on mechanistic studies using a preclinical model, as well as further translational research towards clinical applications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26305294      PMCID: PMC4600606          DOI: 10.1667/RR13919.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  41 in total

1.  Microbeam radiation therapy: tissue dose penetration and BANG-gel dosimetry of thick-beams' array interlacing.

Authors:  F Avraham Dilmanian; Pantaleo Romanelli; Zhong Zhong; Ruiliang Wang; Mark E Wagshul; John Kalef-Ezra; Marek J Maryanski; Eliot M Rosen; David J Anschel
Journal:  Eur J Radiol       Date:  2008-07-07       Impact factor: 3.528

2.  Microbeam radiation-induced tissue damage depends on the stage of vascular maturation.

Authors:  Sara Sabatasso; Jean Albert Laissue; Ruslan Hlushchuk; Werner Graber; Alberto Bravin; Elke Bräuer-Krisch; Stéphanie Corde; Hans Blattmann; Guenther Gruber; Valentin Djonov
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-08-01       Impact factor: 7.038

3.  Biodosimetric quantification of short-term synchrotron microbeam versus broad-beam radiation damage to mouse skin using a dermatopathological scoring system.

Authors:  R C U Priyadarshika; J C Crosbie; B Kumar; P A W Rogers
Journal:  Br J Radiol       Date:  2011-09       Impact factor: 3.039

4.  Cranial irradiation leads to acute and persistent neuroinflammation with delayed increases in T-cell infiltration and CD11c expression in C57BL/6 mouse brain.

Authors:  Michael J Moravan; John A Olschowka; Jacqueline P Williams; M Kerry O'Banion
Journal:  Radiat Res       Date:  2011-07-25       Impact factor: 2.841

5.  Tumor cell response to synchrotron microbeam radiation therapy differs markedly from cells in normal tissues.

Authors:  Jeffrey C Crosbie; Robin L Anderson; Kai Rothkamm; Christina M Restall; Leonie Cann; Saleela Ruwanpura; Sarah Meachem; Naoto Yagi; Imants Svalbe; Robert A Lewis; Bryan R G Williams; Peter A W Rogers
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-01       Impact factor: 7.038

6.  Immunohistochemical localization of caspase-3, caspase-9 and Bax in U87 glioblastoma xenografts.

Authors:  Otilia Zarnescu; Felix Mircea Brehar; Mihaela Chivu; Alexandru Vladimir Ciurea
Journal:  J Mol Histol       Date:  2008-09-24       Impact factor: 2.611

7.  Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines.

Authors:  Judit P Banáth; Susan H Macphail; Peggy L Olive
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

Review 8.  Long-term survival with glioblastoma multiforme.

Authors:  Dietmar Krex; Barbara Klink; Christian Hartmann; Andreas von Deimling; Torsten Pietsch; Matthias Simon; Michael Sabel; Joachim P Steinbach; Oliver Heese; Guido Reifenberger; Michael Weller; Gabriele Schackert
Journal:  Brain       Date:  2007-09-04       Impact factor: 13.501

Review 9.  Glioma and glioblastoma - how much do we (not) know?

Authors:  Ivana Jovčevska; Nina Kočevar; Radovan Komel
Journal:  Mol Clin Oncol       Date:  2013-08-26

10.  An evaluation of dose equivalence between synchrotron microbeam radiation therapy and conventional broad beam radiation using clonogenic and cell impedance assays.

Authors:  Mohammad Johari Ibahim; Jeffrey C Crosbie; Yuqing Yang; Marina Zaitseva; Andrew W Stevenson; Peter A W Rogers; Premila Paiva
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

View more
  5 in total

Review 1.  Nanotube x-ray for cancer therapy: a compact microbeam radiation therapy system for brain tumor treatment.

Authors:  Lei Zhang; Hong Yuan; Christina Inscoe; Pavel Chtcheprov; Michael Hadsell; Yueh Lee; Jianping Lu; Sha Chang; Otto Zhou
Journal:  Expert Rev Anticancer Ther       Date:  2014-12       Impact factor: 4.512

2.  A proof of principle experiment for microbeam radiation therapy at the Munich compact light source.

Authors:  Annique C Dombrowsky; Karin Burger; Ann-Kristin Porth; Marlon Stein; Martin Dierolf; Benedikt Günther; Klaus Achterhold; Bernhard Gleich; Annette Feuchtinger; Stefan Bartzsch; Elke Beyreuther; Stephanie E Combs; Franz Pfeiffer; Jan J Wilkens; Thomas E Schmid
Journal:  Radiat Environ Biophys       Date:  2019-10-26       Impact factor: 1.925

3.  Neurocognitive sparing of desktop microbeam irradiation.

Authors:  Soha Bazyar; Christina R Inscoe; Thad Benefield; Lei Zhang; Jianping Lu; Otto Zhou; Yueh Z Lee
Journal:  Radiat Oncol       Date:  2017-08-11       Impact factor: 3.481

Review 4.  Microbeam radiation therapy - grid therapy and beyond: a clinical perspective.

Authors:  Elisabeth Schültke; Jacques Balosso; Thomas Breslin; Guido Cavaletti; Valentin Djonov; Francois Esteve; Michael Grotzer; Guido Hildebrandt; Alexander Valdman; Jean Laissue
Journal:  Br J Radiol       Date:  2017-07-27       Impact factor: 3.039

5.  Outcomes of Spatially Fractionated Radiotherapy (GRID) for Bulky Soft Tissue Sarcomas in a Large Animal Model.

Authors:  Michael W Nolan; Tracy L Gieger; Alexander A Karakashian; Mariana N Nikolova-Karakashian; Lysa P Posner; Donald M Roback; Judith N Rivera; Sha Chang
Journal:  Technol Cancer Res Treat       Date:  2017-02-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.